Tech Transfer eNews Blog
University-Industry Engagement Advisor

U of Glasgow startup gets £1.3m grant to advance tendon injury treatment

By Jesse Schwartz
Published: June 6th, 2018

A University of Glasgow start-up has secured a £1.3 million (over $1.7M US) grant to develop a novel treatment for soft tissue injuries that affect the tendons.

The funding from nonprofit firm Innovate UK will enable Causeway Therapeutics to flesh out its TenoMiR technology, which blocks disease pathways, restores tendon function and reduces the need for lengthy physiotherapy treatments for patients. The grant will help the startup begin Phase 1 human trials in 24 patients early next year.

The targeted injuries, known as tendinopathies, account for up to 50% of all sporting injuries. According to Causeway co-founder Neal Millar, physiotherapy is only effective in about 50% of cases, leaving the remaining patients with tendons that are weakened and painful.

“Patients are also put off by the prospect of up to 20 weeks of physio, so this fast-track approach to treatment is very appealing,” says Millar. “They want a quicker fix.”

Causeway believes that if the human trials are successful, TenoMiR will be available to patients within five years. “For drug development, this is very quick,” says Millar.

Derek Gilchrist, the start-up’s CEO, comments, “We believe TenoMiR is a novel regenerative therapeutic with the potential to transform the treatment of tendon disease. We’re very grateful to Innovate UK for the funding to hopefully make this possible.”

Source: The Herald

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment